2025年3月13日 · Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 treatment, it is taken with other antivirals. When used to prevent HIV-1 …

DESCOVY for PrEP (pre-exposure prophylaxis) is a once-daily prescription medicine for adults and adolescents at risk of HIV. It helps lower the chances of getting HIV through sex. …

2019年7月24日 · 在中国，Descovy（达可挥，F/TAF，200/10mg和200/25mg）于2018年12月获得批准，联合其他抗逆转录病毒药物，用于治疗成人和青少年（年龄≥12岁，体重≥35kg） …

Descovy (emtricitabine/tenofovir alafenamide) is commonly used for the following conditions. Treatment of HIV (in combination with other medicine) Preventing HIV through sexual contact ( …

DESCOVY ® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding …

Find more information about DESCOVY® (emtricitabine and tenofovir alafenamide) for PrEP (pre-exposure prophylaxis). See Important Facts, including important warnings. FOR US …

【达可挥适应症】： 适用于与其他抗反转录病毒药物联用，治疗成年和青少年 (年龄12岁及以上且体重至少为35kg)的 人类免疫缺陷病毒 1型 (HIV-1)感染（参见 [用法用量]和 [药理毒理]）。 【 …

The U.S. Food and Drug Administration today approved Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) in at-risk adults and adolescents weighing at least 35kg for HIV …

2025年1月30日 · DESCOVY is a two-drug combination of emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV nucleoside analog reverse transcriptase inhibitors (NRTIs), and …

Descovy 是一种抗病毒联合药物，与其它HIV药物一起用于治疗至少12岁且体重至少为17公斤（37磅）的成人和儿童中的HIV（人类免疫缺陷病毒）。 HIV 可导致获得性免疫缺陷综合 …